Page last updated: 2024-08-22

tiletamine hydrochloride and Coronary Disease

tiletamine hydrochloride has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRINA, A; MECIANI, L1
Altschuld, RA; Brierley, GP; Hohl, CM; Merola, AJ; Timerman, AP1

Other Studies

2 other study(ies) available for tiletamine hydrochloride and Coronary Disease

ArticleYear
[POSSIBILITIES AND LIMITATIONS OF THE AMBULATORY TREATMENT OF DISLIPIDEMIA IN CORONARY DISEASE PATIENTS WITH TRIAC (TRIIODOTHYROACETIC ACID). II.USE OF TRIAC ASSOCIATED WITH VITAMIN A AND DIVANILLIDENE-CYCLOHEXANONE (D.V.C.E.)].
    Minerva medica, 1964, Oct-10, Volume: 55

    Topics: Aged; Cholesterol; Coronary Disease; Cyclohexanones; Drug Therapy; Humans; Hyperlipidemias; Lipids; Lipoproteins; Thyroid Hormones; Triiodothyronine; Vitamin A

1964
Cellular glutathione and the response of adult rat heart myocytes to oxidant stress.
    Journal of molecular and cellular cardiology, 1990, Volume: 22, Issue:5

    Topics: Animals; Coronary Disease; Cyclohexanones; Diamide; Glutathione; Heart; Hypoxia; Myocardium; Oxidation-Reduction; Oxygen; Peroxides; Rats; Reperfusion Injury; tert-Butylhydroperoxide

1990